Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Medical Developments International Limited ( (AU:MVP) ) has provided an update.
Medical Developments International Limited has announced its 2025 Annual General Meeting, scheduled for October 10, 2025, at 1 pm AEDT. The meeting will be conducted in a hybrid format, allowing both in-person and virtual attendance via the Computershare platform. Shareholders are encouraged to submit proxy forms as per the instructions provided. This approach reflects the company’s commitment to accessibility and engagement with its stakeholders, potentially impacting shareholder participation and company transparency.
The most recent analyst rating on (AU:MVP) stock is a Buy with a A$0.80 price target. To see the full list of analyst forecasts on Medical Developments International Limited stock, see the AU:MVP Stock Forecast page.
More about Medical Developments International Limited
Medical Developments International Limited operates in the healthcare industry, focusing on the development and distribution of medical products. The company is known for its innovative solutions in pain management and respiratory care, catering to both domestic and international markets.
Average Trading Volume: 146,825
Technical Sentiment Signal: Sell
Current Market Cap: A$64.78M
For a thorough assessment of MVP stock, go to TipRanks’ Stock Analysis page.